Genital marginal failures after intensity-modulated radiation therapy (IMRT) in squamous cell anal cancer: no higher risk with IMRT when compared to 3DCRT

[1]  D. Zwahlen,et al.  PET-CT guided SIB-IMRT combined with concurrent 5-FU/MMC for the treatment of anal cancer , 2017, Acta oncologica.

[2]  Anup Vinayan,et al.  Anal cancer - What is the optimum chemoradiotherapy? , 2016, Best practice & research. Clinical gastroenterology.

[3]  W. Sause,et al.  Vulvar Recurrences After Intensity-modulated Radiation Therapy for Squamous Cell Carcinoma of the Anus , 2016, American journal of clinical oncology.

[4]  F. Lohr,et al.  Genital invasion or perigenital spread may pose a risk of marginal misses for Intensity Modulated Radiotherapy (IMRT) in anal cancer , 2016, Radiation oncology.

[5]  M. Morino,et al.  Locally Advanced (T3-T4 or N+) Anal Cancer Treated with Simultaneous Integrated Boost Radiotherapy and Concurrent Chemotherapy. , 2016, Anticancer research.

[6]  M. Morino,et al.  Early-stage Node-negative (T1-T2N0) Anal Cancer Treated with Simultaneous Integrated Boost Radiotherapy and Concurrent Chemotherapy. , 2016, Anticancer research.

[7]  Charles R. Thomas,et al.  Intensity-modulated Radiation Therapy for Anal Cancer: Results From a Multi-Institutional Retrospective Cohort Study , 2016, American journal of clinical oncology.

[8]  F. Lohr,et al.  Prognostic Relevance of HPV Infection and p16 Overexpression in Squamous Cell Anal Cancer. , 2015, International journal of radiation oncology, biology, physics.

[9]  W. Sause,et al.  Vulvar Recurrences Following Intensity Modulated Radiation Therapy for Squamous Cell Carcinoma of the Anus , 2015 .

[10]  B. Erickson,et al.  NRG Oncology/RTOG 0921: A phase 2 study of postoperative intensity‐modulated radiotherapy with concurrent cisplatin and bevacizumab followed by carboplatin and paclitaxel for patients with endometrial cancer , 2015, Cancer.

[11]  D. Tait,et al.  Proposed genitalia contouring guidelines in anal cancer intensity-modulated radiotherapy. , 2015, The British journal of radiology.

[12]  L. Dawson,et al.  Prospective evaluation of acute toxicity and quality of life after IMRT and concurrent chemotherapy for anal canal and perianal cancer. , 2014, International journal of radiation oncology, biology, physics.

[13]  A. Beddar,et al.  Intensity-modulated Radiation Therapy With Concurrent Chemotherapy for Anal Cancer: Outcomes and Toxicity , 2014, American journal of clinical oncology.

[14]  V. Goh,et al.  Anal cancer: ESMO-ESSO-ESTRO clinical practice guidelines for diagnosis, treatment and follow-up. , 2014, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[15]  V. Goh,et al.  Anal cancer: ESMO-ESSO-ESTRO clinical practice guidelines for diagnosis, treatment and follow-up. , 2014, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[16]  Jacqueline Esthappan,et al.  RTOG 0529: a phase 2 evaluation of dose-painted intensity modulated radiation therapy in combination with 5-fluorouracil and mitomycin-C for the reduction of acute morbidity in carcinoma of the anal canal. , 2013, International journal of radiation oncology, biology, physics.

[17]  D. Tait,et al.  Organ-sparing Intensity-modulated radiotherapy for anal cancer using the ACTII schedule: a comparison of conventional and intensity-modulated radiotherapy plans. , 2013, Clinical oncology (Royal College of Radiologists (Great Britain)).

[18]  Trevor Leong,et al.  Clinical Investigation : Gastrointestinal Cancer Australasian Gastrointestinal Trials Group ( AGITG ) Contouring Atlas and Planning Guidelines for Intensity-Modulated Radiotherapy in Anal Cancer , 2012 .

[19]  Srinivasan Vijayakumar,et al.  Marginal misses after postoperative intensity-modulated radiotherapy for head and neck cancer. , 2011, International journal of radiation oncology, biology, physics.

[20]  Gustavo Viani Arruda,et al.  Audiological findings in patients treated with radio- and concomitant chemotherapy for head and neck tumors , 2009, Radiation oncology.

[21]  P. Deluca.  The International Commission on Radiation Units and Measurements , 2008, Journal of the ICRU.

[22]  K. Goodman,et al.  Squamous cell carcinoma of the anal canal: patterns and predictors of failure and implications for intensity-modulated radiation treatment planning. , 2008, International journal of radiation oncology, biology, physics.

[23]  C. Lemanski,et al.  Optimal organ-sparing intensity-modulated radiation therapy (IMRT) regimen for the treatment of locally advanced anal canal carcinoma: a comparison of conventional and IMRT plans , 2007, Radiation oncology.

[24]  J. Ajani,et al.  Predictors and patterns of recurrence after definitive chemoradiation for anal cancer. , 2007, International journal of radiation oncology, biology, physics.

[25]  Dwight E Heron,et al.  Intensity-modulated radiotherapy for the treatment of vulvar carcinoma: a comparative dosimetric study with early clinical outcome. , 2005, International journal of radiation oncology, biology, physics.

[26]  Ashesh B Jani,et al.  Intensity-modulated radiation therapy (IMRT) in the treatment of anal cancer: toxicity and clinical outcome. , 2005, International journal of radiation oncology, biology, physics.

[27]  T. Vuong,et al.  Contribution of conformal therapy in the treatment of anal canal carcinoma with combined chemotherapy and radiotherapy: results of a phase II study. , 2003, International journal of radiation oncology, biology, physics.

[28]  N. Esiashvili,et al.  Carcinoma of the anus: strategies in management. , 2002, The oncologist.

[29]  M K Martel,et al.  Patterns of local-regional recurrence following parotid-sparing conformal and segmental intensity-modulated radiotherapy for head and neck cancer. , 2000, International journal of radiation oncology, biology, physics.

[30]  H. Bartelink,et al.  Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[31]  G. Tanum.  [Anal cancer. A review]. , 1996, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke.

[32]  W. Sause,et al.  Definitive irradiation and chemotherapy for radiosensitization in management of anal carcinoma: interim report on Radiation Therapy Oncology Group study no. 8314. , 1989, Journal of the National Cancer Institute.

[33]  L. Schwartz,et al.  New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). , 2009, European journal of cancer.

[34]  H. Adami,et al.  The risk of gastrointestinal and other primary malignant diseases following gastric cancer. , 1991, Acta oncologica.